Literature DB >> 19270834

Surgical treatment of native valve Aspergillus endocarditis and fungemic vascular complications.

Kyoung Min Ryu1, Pil Won Seo, Sam-Hyun Kim, Seongsik Park, Jae-Wook Ryu.   

Abstract

Systemic infection with Aspergillus is an opportunistic disease that affects mainly immunocompromised hosts, and is associated with a high mortality rate. It typically occurs in patients with several predisposing factors, but Aspergillus endocarditis of native valves is rare and experience in diagnosis and treatment is limited. We report a case of native valve endocarditis caused by Aspergillus. A 35-yr-old male patient who underwent pericardiocentesis four months previously for pericardial effusion of unknown etiology presented with right leg pain and absence of the right femoral artery pulse. Cardiac echocardiography revealed severe mitral insufficiency with large mobile vegetations, and computed tomographic angiography showed embolic occlusion of both common iliac arteries. We performed mitral valve replacement and thromboembolectomy, and Aspergillus was identified as the vegetation. We started intravenous amphotericin B and oral itraconazole, but systemic complications developed including superior mesenteric artery aneurysm and gastrointestinal bleeding. After aggressive management, the patient was discharged 78 days post surgery on oral itraconazole. He was well at 12 months post discharge but died in a traffic accident 13 months after discharge.

Entities:  

Keywords:  Aspergillus; Endocarditis; Surgery; Vascular Diseases

Mesh:

Substances:

Year:  2009        PMID: 19270834      PMCID: PMC2650974          DOI: 10.3346/jkms.2009.24.1.170

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  8 in total

Review 1.  Aspergillus endocarditis after cardiac surgery.

Authors:  Ismaïl El-Hamamsy; Nicolas Dürrleman; Louis-Mathieu Stevens; Louis P Perrault; Michel Carrier
Journal:  Ann Thorac Surg       Date:  2005-07       Impact factor: 4.330

2.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

Review 3.  Fungal endocarditis: evidence in the world literature, 1965-1995.

Authors:  M E Ellis; H Al-Abdely; A Sandridge; W Greer; W Ventura
Journal:  Clin Infect Dis       Date:  2000-12-12       Impact factor: 9.079

4.  Aspergillus valve endocarditis in patients without prior cardiac surgery.

Authors:  T Gumbo; A J Taege; S Mawhorter; M C McHenry; B H Lytle; D M Cosgrove; S M Gordon
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

5.  Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia.

Authors:  D McCracken; R Barnes; C Poynton; P L White; N Işik; D Cook
Journal:  J Infect       Date:  2003-11       Impact factor: 6.072

Review 6.  Aspergillus endocarditis in a native valve after amphotericin B treatment.

Authors:  Anastasia N Kotanidou; Epaminonthas Zakynthinos; Ilias Andrianakis; Dimitrios Zervakis; Ioannis Kokotsakis; Theodoros Argyrakos; Athina Argiropoulou; Georgia Margariti; Emmanuel Douzinas
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

7.  Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem.

Authors:  M L Fernández-Guerrero; C Verdejo; J Azofra; M de Górgolas
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

Review 8.  Fungal endocarditis, 1995-2000.

Authors:  Lígia C Pierrotti; Larry M Baddour
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

  8 in total
  1 in total

1.  Invasive aspergillosis in an immunocompetent patient with fever and a cardiac mass.

Authors:  Matthew Labarbera; Lester B Jacobson
Journal:  Infect Dis Rep       Date:  2011-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.